This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Institut Gustave Roussy, Transgene S.a.. Active years: 2020-2026.
Company Filing History:
2 out of 101 
2 out of 159 
Years Active: 2020-2026
Title: Laetitia Fend: Innovator in Cancer Treatment
Introduction
Laetitia Fend is a prominent inventor based in Le Kremlin-Bicetre, France. She has made significant contributions to the field of cancer treatment through her innovative research and patents. With a total of 2 patents, her work focuses on the combination of oncolytic viruses with immune checkpoint modulators.
Latest Patents
Laetitia Fend's latest patents include a groundbreaking invention that provides a combination comprising at least an oncolytic virus and one or more immune checkpoint modulators for the treatment of proliferative diseases such as cancer. This invention also relates to a kit that includes the oncolytic virus and the immune checkpoint modulators in separate containers. Additionally, it concerns a pharmaceutical composition that comprises an effective amount of the oncolytic virus and the immune checkpoint modulators.
Career Highlights
Throughout her career, Laetitia Fend has worked with esteemed organizations such as Institut Gustave Roussy and Transgene S.A. Her research has been pivotal in advancing the understanding and treatment of cancer, showcasing her dedication to improving patient outcomes.
Collaborations
Laetitia has collaborated with notable colleagues, including Xavier Preville and Laurence Zitvogel. These partnerships have further enriched her research and contributed to the development of innovative cancer therapies.
Conclusion
Laetitia Fend's contributions to cancer treatment through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to inspire advancements in medical research and therapy.